Unnamed Medicine: Receives 1.35 billion yuan in dividends from Beijing Kexing.

Miming Pharmaceutical Announcement: The company recently received a dividend amount of RMB 135 million from its equity investment company, Beijing Kexing Bioproducts Co., Ltd. According to the resolution of Beijing Kexing's board of directors, a portion of the accumulated distributable profits up to December 31, 2024 will be distributed to shareholders in proportion to their contributions to the registered capital of Beijing Kexing. The company holds 26.91% equity in Beijing Kexing and will receive a cash dividend of RMB 135 million. As of the date of this announcement, the company has received the full cash dividend amount mentioned above.